Sculpting Metal‐binding Environments in De Novo Designed Three‐helix Bundles by Plegaria, Jefferson S. & Pecoraro, Vincent L.
DOI: 10.1002/ijch.201400146
Sculpting Metal-binding Environments in De Novo
Designed Three-helix Bundles
Jefferson S. Plegaria and Vincent L. Pecoraro*[a]
1. Introduction
Proteins acquire metal ions, such as iron, copper, or zinc,
to perform essential functions in biology, including cata-
lytic reactions, signal transduction, transport and storage
of small molecules, and redox chemistry.[1] Metallopro-
teins play a central role in various biological systems, in-
cluding photosynthesis and respiration, two systems that
sustain all life on earth. Recent initiatives by the scientific
community to find alternatives to carbon-based fuels
have turned to the bioenergetic processes in photosynthe-
sis for inspiration to create a “greener planet”. Before ef-
ficient artificial photosynthetic systems can be realized,
fundamental research on the individual metalloproteins
and metalloenzymes in this multifaceted system must be
explored. Ultimately, the knowledge gained from this re-
search will bring us one step closer to fully understanding
and harvesting the rewards of many biological systems.
Protein design is a biologically relevant approach used
to study the concept of the structure-function relationship
in native proteins.[2–4] This emerging approach has two
central design strategies: the first is protein redesign,[2]
and the second is de novo design.[2–7] Protein redesign in-
volves modifying or incorporating the desired metal-bind-
ing site in an existing native protein scaffold. The second
approach, which is unquestionably the most challenging
strategy, employs first principles to design peptide or pro-
tein scaffolds from scratch, with an amino acid sequence
not found in nature.[6] It allows one to tailor-design a se-
quence that forms the proper hydrophobic, electrostatic,
and hydrogen-bonding interactions that will manifest into
a well-defined peptide scaffold, an important characteris-
tic of native proteins. De novo protein design offers
a novel approach in studying the mechanisms behind pro-
tein folding and exploring the active sites of native pro-
teins in a simplified or unrelated fold. The knowledge
gained from this approach could ultimately provide in-
sight into the fundamental processes of biological sys-
tems, thus allowing the possibility of producing new met-
alloproteins, with higher stability and superior efficiency
than native proteins, for many biotechnological applica-
tions.
We are actively involved in the de novo protein design
of peptide scaffolds to understand the metal active sites
of metalloenzymes (Figure 1a), as well as metalloproteins
involved in electron transfer (ET, Figure 1b), metal-regu-
lated gene expression,[1,8] and metallochaperones.[1] These
last systems are a subset of metalloproteins used by mi-
croorganisms to control the levels of essential transition
metal ions (Fe, Cu, Zn, and Mn), decrease levels of toxic
metals (Hg, As, Pb, and Cd) within their cells, and to
ensure proper trafficking and insertion of metals into en-
zymes or secretory vesicles. This review focuses on a de
novo designed scaffold, a3D,
[9] a single polypeptide chain
that folds into a three-helix bundle (THB). Section 2 will
first briefly cover our work and progress with three-
stranded coiled-coil (3SCC) constructs. It will then be fol-
lowed by the achievement of DeGrado and coworkers in
producing a THB scaffold. Next, section 3 will cover our
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current work and first approach in functionalizing the
a3D scaffold through the incorporation of symmetric
metal-binding sites to yield peptides a3DIV
[10] and
a3DH3.
[11] Our work comprises a short description of the
solution structure of a3DIV (unpublished work), an a3D
analogue that contains a tris(cysteine) motif, and its
heavy metal binding properties. In addition, we will also
describe our progress with a carbonic anhydrase model,
a3DH3, an iteration of a3D that contains a tris(histidine)
site. The last section will discuss future designs that aim
to improve metal binding in a3DIV and catalytic activity
in a3DH3, as well as to model an asymmetric His2CysMet
copper site.
2. Development of De Novo Designed Scaffolds
2.1. Three-stranded Coiled-coil Constructs
The most common de novo designed peptides use
a heptad repeat sequence (abcdefg) that self-assemble
into a parallel 3SCC tertiary structure (Figure 2a).[7,14,15]
Much of our effort and success in the de novo design
field has been carried out using the 3SCC scaffold of
TRI,[16–31] Grand (Gr),[24,26,32,33] and BABY[18,33,34] peptides,
as well as in CoilSer (CS),[22,27,28,33,35–37] which serves as
a crystallographic analogue for TRI (Table 1). A metal-
binding site is generated by incorporating a cysteine or
penicillamine residue at the “a” (Figure 2b) or “d” (Fig-
ure 2c) position in a 3SCC scaffold.[37] We discovered that
the subtle difference between the “a” and “d” positions
can produce distinctive outcomes in heavy metal binding
affinity and geometry, which can be attributed to the pre-
organization of the sulfur ligands prior to metal bind-
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Figure 1. a) Crystal structure of a zinc metalloenzyme, human car-
bonic anhydrase II (PDB code 3KS3).[12] b) Crystal structure of
a copper electron-transfer metalloprotein, plastocyanin (PDB code
1PLC),[13] which is part of the cupredoxin family.
Figure 2. a) Crystal structure of [Hg(II)]S[Zn(II)(H2O/OH
)]N-
(CSL9PenL23H)3
n+ (PDB code 3PBJ), which is used as a crystallo-
graphic model for the [Hg(II)]S[Zn(II)(H2O/OH
)]N(TRIL9CL23H)3
n+ CA
model.[27, 30] This bimetallic 3SCC construct contains a Zn(II) and
Hg(II) atom bound to a His-N3 and Pen-S3 site, respectively. b) Sym-
metric “a” site Cys residues in CSL9C (PDB code 3LJM)[37] contain Sg
ligands that orient inside the core. c) Symmetric “d” site Cys resi-
dues in CSL19C (PDB code 2X6P)[37] include Sg ligands that orient
towards the interhelical interface, forming a larger metal-binding
site than Cys “a” sites.
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ing.[14,17] Overall, we have gained a deeper understanding
in the metallobiochemistry of heavy metals, such as
As(III),[19,28,35] Cd(II),[14,19–22,24–26,32] Hg(II),[16–19,22,23,25,27,34]
and Pb(II),[21,28,33,38] in a tristhiolate site. We have demon-
strated how to control the coordination number and ge-
ometry of Cd(II)[14,24,26,32] and Hg(II),[18,19,23,25] determined
the affinity for Cd(II)[21] and Pb(II),[21,33] based on site
preferences for “a” or “d” sites of the Cys residues, and
elucidated the effects of the core aliphatic groups in the
second coordination sphere on the molecular recognition
of Cd(II)[14,24,26] and Pb(II).[33] This work on heavy metal
chemistry in 3SCC is a culmination of over 10 years of re-
search and has given us a solid foundation for modeling
catalytic sites of natural metalloenzymes.
Using the 3SCC scaffold, our work has progressed
into modeling the symmetric tris(histidine) metal-binding
site found in carbonic anhydrase (CA)[27,30] and nitrite re-
ductase (CuNiR).[29,31] The [Hg(II)]S[Zn(II)(H2O/
OH)]N(TRIL9CL23H)3
n+ CA model (Figure 2a) of Zas-
trow et al. contains a structural Hg(II)S3 site towards the
N-terminal end of the TRI fold (Figure 3a) and
a Zn(II)N3O catalytic site at the C-terminal end (Fig-
ure 3b).[27] This construct is an artificial metalloenzyme
that catalyzes the hydration of CO2 with an efficiency
faster than any other small molecule model and is within
~500-fold of CAII, the most active isoform of carbonic
anhydrase. Further, the CuNiR models of Tegoni et al.[29]
and Yu et al.[31] are capable of multiple turnover catalysis
for the one electron reduction of nitrite using ascorbate,
and is the first mononuclear redox enzyme that was iso-
lated via de novo protein design. Nevertheless, the metal-
binding sites of native proteins, such as the ET site in cu-
predoxins, are often asymmetric and contain a mixed-
ligand (O, N, or S) environment (Figure 3c).[13] Further,
the coordination environment of metal centers contains
secondary residues that participate in hydrogen-bonding
networks (Figure 3c), such as in CA,[12,39] or in electrostat-
ic interactions, which are essential in the catalytic or
redox activity of many metalloproteins. Even though we
have successfully modeled a variety of metal centers and
performed catalytic reactions in our 3SCC scaffolds, its
self-assembling nature makes it challenging to obtain
asymmetric constructs. Therefore, to achieve asymmetric
metal binding sites, we have expanded our work to ac-
quire, and then later develop, a single polypeptide se-
quence that folds into a preformed three-helix bundle
fold.
2.2. From Three-stranded Coiled-coil to a Three-helix Bundle
Fold
The THB fold is used as a molecular recognition domain
found in many biological systems including immunoglo-
bulin G, DNA binding proteins, and various enzymes. In-
spired by its universal presence and diverse function in
nature, DeGrado and coworkers aimed to create a de
novo designed antiparallel THB scaffold. Bryson et al.
used the sequence of CS as the foundation, because its X-
ray crystal structure[40] was observed to pack in an anti-
parallel manner, where the helices orient in an up-up-
down manner, instead of the predicted parallel style.[41]
Table 1. Amino acid sequence of de novo designed 3SCC analogues.[a]
Peptide Sequence
abcdefg abcdefg abcdefg abcdefg abcdefg
CoilSer Ac-E WEALEKK LAALESK LQALEKK LEALEHG NH2
Baby Ac-G LKALEEK LKALEEK LKALEEK G-NH2
TRI Ac-G LKALEEK LKALEEK LKALEEK LKALEEK G-NH2
Grand Ac-G LKALEEK LKALEEK LKALEEK LKALEEK LKALEEK G-NH2
[a] Leucine residues at the “a” or “d” positions are mutated to metal-binding residues such as cysteine, penicillamine, or histidine. Mutation
of Leu residues to Cys and His at the 9th and 23rd positions, respectively, is designated as TRIL9CL23H.
Figure 3. a) Top-down view of the trigonal Hg(II)S3 site in
[Hg(II)]S[Zn(II)(H2O/OH
)]N(CSL9PenL23H)3
n+ , which serves as a struc-
tural motif in the scaffold.[27] b) Top-down view of the Zn(II)N3O site
in [Hg(II)]S[Zn(II)(H2O/OH
)]N(CSL9PenL23H)3
n+ , which is capable of
CA activity.[27] c) 2His, Cys and Met copper binding site in plasto-
cyanin, illustrating an asymmetric metal center.[13] d) Zinc metal-
binding site in CAII, which contains a tris(histidine) site and hydro-
gen-bonding residues, such as Thr199, which are essential in catal-
ysis.[12, 39] Reprinted with permission from Ref. [4] . Copyright 2014
American Chemical Society.
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Using a hierarchical approach, a3D
[9] was the final prod-
uct and was isolated through a step-wise process (3
design rounds) of modifying helix-capping interactions
which dictate the topology of the bundle, electrostatic in-
teractions which orient the desired helix-helix pairing to
avoid alternative states, and hydrophobic interactions to
achieve a well-packed core.
In the first round, Bryson et al. shortened the sequence
of CS by one heptad repeat to yield three 21-residue heli-
ces in a3A (Table 2).
[41] To achieve an antiparallel strand,
Glu and Lys residues in helix 2 at the “e” and “g” posi-
tions were reversed from the original positions in CS.
Next, two simple loops of Gly-Asn and Pro-Gly-Asn
were incorporated between helix 1 and 2 and helix 2 and
3, respectively, to serve as hairpin loops. This motif is es-
sential for directing the topology of the bundle, which can
adopt clockwise or a counterclockwise orientation. a3A
was observed to form monomer/dimer/trimer species in
solution, indicating that the hairpin loops were not suc-
cessful in stabilizing intermolecular interactions. Round
two designs were a direct response to these issues.
Sequence a3B was designed to contain stronger helix
stop signals to accurately direct the formation and confor-
mation of the loops. This was achieved by lengthening
residues in the loops and adding Asn residues as a helix
stop signal in the form of helix capping boxes (Asn-Pro-
Asp-Glu between helix 1 and 2 and Asn-Pro-Glu between
helix 2 and 3). a3B is monomeric in solution but still re-
tains some characteristics of a molten globule, an unde-
fined folded state with several energetically equal confor-
mations.
Lastly, the final round of design focused on repacking
the hydrophobic core, reordering the residues involved in
interhelical electrostatic interactions, and further enhanc-
ing helix-capping interactions to prevent nonnative char-
acteristics in a3B. First, an Asn was replaced with a Ser as
the helix-capping residue between helix 1 and 2. Next,
the positions of the Lys and Glu residues were redesigned
to force a counterclockwise topology in the bundle
(Figure 4). The clockwise form was destabilized by careful
placement of charged residues at the “e” and “g” posi-
tions. In helix 1, only positively (+) charged residues
were placed both at the “e” and “g” positions; while in
helix 3, negatively () charged residues were assigned in
those corresponding sites. For helix 2, the “e” sites were
given only  charged residues, whereas the “g” sites re-
ceived + charged residues. Furthermore, some Lys resi-
dues were changed to Arg to reduce redundancy in the
sequence and provide added stability gained from an
Arg-Glu salt-bridge interaction. Lastly, using a genetic re-
packing algorithm, the hydrophobic residues at the “a”
and “d” positions were altered to include various nonpo-
lar residues such Ala, Val, Ile, Leu, and Phe residues. The
native-like property of a3C was characterized in tandem
with a3B, and it was demonstrated to exhibit thermody-
namic and spectroscopic properties of a well-defined and
folded protein.
2.3 Solution Structure of a3D, the Final Iteration in the THB
Design
DeGrados and coworkers work had a significant impact
on the field of de novo protein design through the design,
preparation, and characterization of a3D, a 73-residue
peptide with a single conformation in solution and
a unique native-like fold.[9] Its well-packed core and
Table 2. Amino acid sequence of THB analogues.[a]
Peptide Sequence Design Purpose/Function
abcdefg abcdefg abcdef loop
a3A EWEALEKK LNALESK LQALEK G Iteration of CS
NWEALKKE LNALKSE LQALKK PG
EWEALEKK LNALESK LQALEHG
a3B EWEALEKK LAALESK LQALEK GG Iteration of a3A
NPDEWAALKKE LAALKSE LQALK GKG
NPEWEALEKK LAALESK LQALEHG
a3C SWAEFKER LAAIKSR LQAL GG Iteration of a3B
SEAELAAFEKE IAAFESE LQAYK GKG
NPEVEALRKE AAAIRSE LQAYRHN
a3D MGSWAEFKQR LAAIKTR LQAL GGS Molecular
EAELAAFEKE IAAFESE LQAY KGKG recognition domain
NPEVEALRKE AAAIRDE LQAYRHN
a3DIV MGSWAEFKQR LAAIKTR CQAL GGS Heavy metal
EAECAAFEKE IAAFESE LQAY KGKG peptide
NPEVEALRKE AAAIRDE CQAYRHN Cd(II), Hg(II) and Pb(II)
a3DH3 MGSWAEFKQR LAAIKTR HQAL GGS Carbonic anhydrase
EAEHAAFEKE IAAFESE LQAY KGKG
NPEVEALRKE AAAIRDE HQAYRHNGSGA model
[a] The sequences are prepared in heptads. Residues that are underlined and bolded were changed from the previous design. The a3A was al-
tered from the CS sequence.
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single topology led to a solution structure; at the time,
this was a very challenging feat to achieve (Figure 5). In
contrast to its predecessors (a3A, a3B, and a3C), which
were chemically synthesized, Walsh et al. expressed a3D
in E. coli. Met1, Gly2, Gln9, Thr16, and Asp65 were
changed in a3C to generate the sequence of a3D
(Table 2). Thermodynamic studies (chemical and thermal
denaturation) showed a scaffold that is fully folded at
room temperature (pH 3–7), with a melting temperature
(Tm) in the range 80–95 8C, heat capacity (DCp) of 10–
12 calmol1K1 per residue, Gibbs free energy of unfold-
ing (DGU) of 5.1 kcalmol
1, and an enthalpy (DHDSC)
value of 44 kcalmol1.
The solution structure of a3D was obtained from sever-
al three-dimensional (triple resonance, TOCSY, and
NOESY) NMR experiments at pH 5.5. About 1260 ex-
perimental restraints were used in solving the structure,
which comprises of 1191 distances and 69 dihedral angles
(f and c1). The ensemble of 13 structures demonstrate
a high quality structure, with RMSD values of 1.06, 0.75,
and 1.61  for the backbone atoms (residues 1–73, N, Ca,
C), the backbone atoms in the structure regions (residues
4–21, 24–45, 51–70, N, Ca, C), and the heavy atoms (resi-
dues 1–73), respectively. The helical bundle adopts a coun-
terclockwise topology, which is confirmed by the interhel-
ical tilt angles of the lowest energy structure (W1,2=
1658, W1,3=178 and W2,3=1718). Further, the c1 tor-
sional angles of 14 core residues assumed a single confor-
mation in the ensemble, demonstrating a well-packed
apolar core. Ultimately, the success of a3D demonstrates
that the de novo design strategy could now serve as
a practical method in constructing complex and multi-
stranded scaffolds from a single sequence.
Furthermore, additional solution studies revealed that
the backbone 15N and 13C atoms are well-ordered, with
restrictive motion on the pico- to nanosecond scale,[42] rel-
ative hydration of the backbone amides,[43] and a folding
time scale for a3D in the 1–5 ms range.
[44] In addition, mu-
tation studies showed that replacing Ala60 with a Leu or
an Ile resulted in 1.5 kcalmol1 net gain in stability.[45]
3. Functionalizing a3D Framework
3.1. Construction and Structure of a Symmetric Heavy Metal
Binding Peptide
a3D offers a novel opportunity to add function to a well-
defined de novo designed scaffold (Figure 6a). We rede-
signed the sequence of a3D by introducing a tris(cysteine)
motif to emulate the type of MS3 environments that have
been proposed for the metalloregulatory proteins
MerR,[46–48] ArsR/SmtB,[49] and CadC/CmtR[49–51] (an MS4
or MS3O environment). At the C-terminal end of the
bundle, three Leu residues at positions 18, 28, and 67 are
inside a “hydrophobic box” which is formed by Ile14,
Leu21, Phe31, Ile63, and Tyr70. Chakraborty et al. func-
tionalized a3D by mutating the “a” site Leu residues to
Cys (Leu18Cys, Leu28Cys, and Leu67Cys) to produce
Figure 4. a) Carton scheme representing interhelical electrostatic
interactions between a-helices. The circles symbolize a-helices and
are illustrated from either the N- or C-terminal end. The numbers
correspond to their sequential positions in the THB. The “” signs
denote negatively charged Glu residues in either the “e” or “g” po-
sitions, while “+ ” signs indicate positively charged Lys and Arg res-
idues at the same positions. Solid and dashed lines represent loops
that connect helices. a) CS was designed to form a parallel dimer;
instead it was observed to pack into an antiparallel trimer with un-
favorable interactions with like charges. b) In a3A and a3B, the ar-
rangement of the interhelical electrostatic interactions allow for
both topologies to be possible. c) The clockwise form was destabi-
lized by careful placement of charged residues at the “e” and “g”
positions. In helix 1, only positively (+) charged residues were
placed both at the “e” and “g” positions; while in helix 3, negative-
ly () charged residues were assigned in those corresponding
sites. For helix 2, the “e” sites were given only  charged residues,
whereas the “g” sites received + charged residues. Reprinted with
permission from Ref [41]. Copyright 1998 The Protein Society.
Figure 5. Solution structure of a3D (PDB code 2A3D) demonstrat-
ing a THB fold.[9]
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a3DIV (Figure 6b).
[10] This forms a metal-binding site
with two “a” Sg ligands and one pseudo “a” site at the
28th position in the antiparallel strand.
We recently solved the apo structure of a3DIV at
pH 7.0 (unpublished work) to investigate the effects of
a Leu to Cys mutation and the preorganization of the
tris(cysteine) site prior to metal binding. Like the parent
structure a3D, the three-helix bundle of a3DIV adopts
a counterclockwise topology with similar interhelical tilt
angles. The structure shows that the tris(cysteine) metal-
binding site can easily accommodate heavy metals like
Cd(II), Hg(II), and Pb(II), with the 20 lowest energy con-
formations of the three Cys residues showing great uni-
formity, indicating a rigid structure. The structure of
a3DIV illustrates that we were successful in carving out
a metal-binding site within a3D without significantly com-
promising its overall structure or stability.
3.2. Characterizing Heavy Metal Binding Properties of a3DIV
Chakraborty et al. determined, via circular dichroism
studies, that apo a3DIV is well-folded in solution in the
range pH 6–9 and has a chemically-induced DGU of
2.5 kcalmol1.[10] This DGU is half of the reported value
for a3D, exhibiting a loss in stability after the removal of
the packing Leu residues. a3DIV stoichiometrically binds
Hg(II), Pb(II), and Cd(II) in a pH-dependent manner.
The tris(cysteine) site forms a linear [Hg(II)S2(SH)] com-
plex below pH 6.0 and a trigonal [Hg(II)S3]
 complex
above pH 8.5; a mixture of both species were observed
under intermediate pH conditions (~pH 7.5). Above
pH 5.0, Pb(II) and Cd(II) bound a3DIV to generate trigo-
nal pyramidal [Pb(II)S3]
 and pseudo-tetrahedral
[Cd(II)S3(N/O)]
 geometry, respectively. These coordina-
tion modes were determined using various spectroscopic
methods and were compared with the physical properties
of 3SCC analogues (Table 3). The absorption features of
all three metallated species were characterized via UV/
Vis spectroscopy. 113Cd and 199Hg NMR, and 111mCd and
199mHg perturbed angular correlation spectroscopy (PAC)
spectra were obtained for Cd(II)- and Hg(II)-a3DIV to
confirm their binding modes in solution. These NMR[52,53]
techniques allow us to study the coordination environ-
ment at the millisecond timescale, while the PAC[54] tech-
niques can further confirm and elucidate speciation be-
havior at the micro- to nanosecond timescale. The chemi-
cal shift environments of 113Cd and 199Hg NMR are espe-
cially sensitive to the coordination environment. The
combination of metal NMR and PAC provides a powerful
tool in identifying the primary ligand environment, as
well additional coordinating ligands, such as solvent mole-
cules or residues that are several layers removed. Further-
more, we have significantly advanced the development of
207Pb NMR,[33,38] using our TRI and CS peptides, by prov-
ing how extremely sensitive this nucleus is to subtle
changes in the apolar layer above the Pb(II)S3 complex,
with a chemical shift range of 5800–5500 ppm.
The ligand-to-metal charge transfer (LMCT) bands of
metallated a3DIV
[10] in the UV/Vis studies exhibited
metal-thiolate transitions comparable with the reported
values for its TRI counterparts (Table 3). The Cd(II)-
a3DIV species has a lmax at 232 nm (18, 200 M
1 cm1)
and Pb(II)-a3DIV exhibits four absorption bands, with
a lmax at 236 nm (18,000 M
1 cm1) and a characteristic
band at 346 nm (3150 M1 cm1). The trigonal complex
that forms in Hg(II)-a3DIV demonstrates three bands,
with a lmax at 247 nm (12,500 M
1 cm1), while the linear
species contains one lmax at 240 nm (850 M
1 cm1). From
further UV/Vis work, the [Pb(II)S3]
 complex was deter-
mined to have a lower limit binding constant of 2.0
107 M1, while the [Cd(II)S3(N/O)]
 complex had a lower
limit value of 3.1107 M1.
The linear complex of 199Hg(II)-a3DIV has a chemical
shift of 938 ppm, whereas the trigonal form experiences
a downfield shift to 244 ppm. The 199Hg NMR spectrum,
at an intermediate pH (7.5), contains both the linear and
trigonal planar species. The 199mHg-a3DIV spectra from
the PAC analysis confirm this pH-dependent speciation
behavior (Figure 7). The PAC parameter, nQ, was deter-
mined to be 1.48(2) and 1.11(2) GHz for the linear and
trigonal complex, respectively, which matches well with
Figure 6. a) Schematic representation of designing a metal center
in the a3D scaffold. b) Top-down view of the tris(cysteine) site in
a3DIV modeled from the a3D structure. c) Top-down view of the
tris(histidine) site in a3DH3 modeled from the a3D structure.
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the reported nQ values for 2- and 3-coordinate Hg(II) in
3SCC constructs.[31] These nQ values were also observed at
pH 7.5, demonstrating the presence of both linear and
trigonal planar species. In hindsight, these results show
that we have created a peptide scaffold that can finely
control the coordination environment of Hg(II) ions. Ad-
ditionally, Chakraborty et al. observed that the addition
of 2 equivalents of Hg(II) induced the formation of
a dimer species, where Hg(II) atoms bridge two peptides
through a linear complex.[55] This dimer species was con-
firmed with both 199Hg(II) NMR and 199mHg(II) PAC.
The 113Cd NMR spectrum of 113Cd-a3DIV shows over-
lapping resonance peaks at 583 and 595 ppm. Based on
these chemical shift positions, this result indicates the
presence of two 4-coordinate Cd(II) species. 111mCd PAC
was again collected to supplement the 113Cd NMR result,
but in this case, it was used to define the two species ob-
served in the NMR time scale. The 111mCd PAC showed
three nuclear quadrupole interactions at 0.35, 0.27, and
0.17 radns1. The peaks at 0.35 and 0.27 radns1 agree
well with a CdS3O complex with two conformations, endo
and exo. The frequency value at 0.17 radns1 fitted well
with CdS3N species, where the N ligand was proposed to
originate from the imidazole ring of His72. Overall, not
only did the combination of metal NMR and PAC pro-
vide a way to accurately characterize our de novo de-
signed peptides, it also gave powerful insights into how
toxic heavy metals may interact with native proteins.
3.3. Constructing a Symmetric Metalloenzyme Site in a3D
Our work with a3D was further expanded to incorporate
a tris(histidine) metal-binding site reminiscent of carbonic
anhydrase (Figure 6c). This metalloenzyme plays a vital
role in respiration, vision, cancer metathesis, regulation of
acid-base equilibria, and other processes in animals,
plants, and bacteria. Human carbonic anhydrase II is one
of the most efficient enzymes (approaching the diffusion
limit) which catalyzes the reversible interconversion be-
tween CO2 and HCO3
 .[56] Even though the mechanism,
Table 3. Physical parameters of metallated a3DIV compared to 3SCC constructs.
[a]
Complex l [nm] d (ppm) w0 (rad/ns), h nQ(GHz), h ref
(De [M1 cm1]) 113Cd 199Hg 207Pb 111mCd PAC 199mHg PAC
583 0.350(6), 0.00(1)[b] [10]
Cd(a3DIV) 232 (18 200) 595 0.268(4), 0.18(7)
[c]
0.170(2), 0.50(2)[d]
Hg(a3DIV) [10]
3-coordinate 247 (12 500), 265 (8400), 295 (3900) 244 1.11(2), 0.40(3)
2-coordinate 240 (850) 938 1.48(2), 0.15(5)
Pb(a3DIV) 236 (18 000), 260 (14 400), 278 (9100), 346 (3150) [10]
Cd(TRIL12C)3 231 (20 600) 619 0.233(8), 0.25(12) [19]
0.468(9), 0.12(10)
Cd(TRIL16C)3 232 (22 600) 625 0.337(2), 0.23(2) [19]
0.438(4), 0.20(3)
Hg(TRIL9C)3 185 1.164(5), 0.25(2) [23]
Hg(TRIL9C)2 908 1.558(7), 0.23(1) [23]
Hg(TRIL19C)3 230 (21 300), 247 (15 000), 297 (5500) 316 [23, 25]
Hg(TRIL16C)3 247 (16 800), 265 (10 600), 295 (5000) 179 [16]
Hg(TRIL16C)2 240 (2700) 834 [16]
Pb(TRIL12C)3 238 (17 000), 278 (12 300), 343 (3700) 5814
[e] [21, 33]
Pb(TRIL16C)3 236 (18 500), 260 (16 500), 278 (14 500), 346 (3400) 5612
[f ] [21, 33]
[a] UV/Vis, metal (113Cd, 199Hg and 207Pb) NMR and (111mCd and 199mHg) PAC. L9C and L16C are “a” site constructs, while L12C and L19C are
“d” sites. [b] CdS3O in exo conformation. [c] CdS3O in endo conformation. [d] CdS3N species. [e]
207Pb chemical shift for Pb(CSL12C)3; ref 33.
[f ] 207Pb chemical shift for Pb(CSL16C)3; ref 33.
Figure 7. Schematic representation of the pH- and stoichiometric-
dependent behavior of Hg(II) species in a3DIV.
[10,55]
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structure, and inhibition have been previously studied, de
novo protein design still offers a novel approach to study
and replicate an important function of a native metal-
loenzyme in a simplified peptide system. We have previ-
ously demonstrated a carbonic anhydrase model in a bi-
metallic 3SCC construct [Hg(II)]S[Zn(II)(H2O/
OH)]N(TRIL9CL23H)3
n+ and Zastrow et al. reported
this model to be within 500-fold of the fastest isozyme
(CAII), which is the fastest CA model to date (Fig-
ure 2a).[27,30] Nevertheless, CAII contains residues that
participate in hydrogen-bonding networks, and the self-
associating nature of our 3SCC construct limits its use in
preparing asymmetric sites. Thus, we remodeled the zinc
catalytic site of CA into a3D to recapitulate CA activity.
Now that this is established, we hope to add hydrogen-
bonding residues in the second coordination sphere of the
Zn(II) complex in future CA designs of a3D.
Cangelosi et al. incorporated a tris(histidine) site in
a3D to yield a3DH3 (Figure 6c), a de novo designed met-
alloenzyme model that exhibited CA activity.[11] The se-
quence of a3DH3 (Table 2) was expanded by four residues
(77 in a3DH3), which led to a peptide with increased
yields during expression, from ~100 to 230 mgL1. His
residues were substituted at positions 18, 28, and 67, and
a His72Val mutation was also incorporated to eliminate
a competing ligand. At pH 9.0, the apo form folds well in
solution (82% folded), according to the 208 and 222 nm
bands that were observed in the CD spectrum, and has
a chemically induced DGU of 3.1 kcalmol
1. The Zn(II)-
a3DH3 complex was characterized using UV/Vis and X-
ray absorption spectroscopies, while its CA activity was
determined with Khalifahs stopped-flow indicator tech-
nique.[57]
Using a UV/Vis Zincon colorimetric assay,[58] the appar-
ent Zn(II) binding constant to a3DH3 was determined to
be 15040 nM at pH 7.5 and it strengthened to 59
9 nM at pH 9.0. When compared with CA, these affinity
values are only two orders of magnitude weaker
than the recent value determined for CAII (0.45 nM),[56]
and stronger than the [Hg(II)]S[Zn(II)(H2O/
OH)]N(TRIL9CL23H)3
n+ (0.80.1 mM at pH 7.5 and
0.220.06 mM at pH 9.0)[30] CA model. From extended
X-ray absorption fine structure spectroscopy, the Zn(II)-
a3DH3 coordination environment (at pH 9.0) fitted well
to a site that contains 1 oxygen (from an exogenous H2O
or OH molecule) and 3 nitrogen atoms from each His
residue bound to a Zn(II) atom at 1.90 and 1.99 , which
matches well with the Zn complex in CAII with a ZnN/
O bond length of 1.98  (pH 7.0).[56]
To demonstrate the success of a3DH3 as a metalloen-
zyme, Cangelosi et al. performed a stopped-flow CO2 hy-
dration assay using Khalifahs indicator technique. The
maximal catalytic efficiency (kcat/KM), which was derived
from the kcat/KM values for pH 8–9.5, and the kinetic pKa
for the deprotonation of Zn(II)-bound water to yield the
active [Zn(II)N3O]
1+ hydroxide complex were calculated
to be 6.9104 Lmol1 s1 and 9.4, respectively. When com-
pared with two small molecule models, Zn(II)(tris(4,5-di-
n-propyl-2-imidazolyl)-phosphine)[59] and Zn(II)nitrilot-
ris(2-benzimidazolylmethyl-6-sulfonate),[60] which both
have a Zn(II)N3O complex and show CA activity, Zn(II)-
a3DH3 significantly outperformed these models, exhibit-
ing a second-order rate constant (k2) that was 14-fold
higher. The CO2 hydration efficiency of Zn(II)-a3DH3 is
2.6-fold slower than its 3SCC counterpart,[27] 1400-fold
less efficient than CAII,[61] but only 11-fold slower than
CAIII.[62] The decrease in the catalytic activity, as com-
pared with our 3SCC CA model, could be as a result of
a weaker dipole, less-symmetric environment for the imi-
dazole rings, and difference in the electrostatics at the
metal-binding site in the antiparallel bundle of a3DH3.
Furthermore, a product inhibition assay was performed
on Zn(II)-a3DH3, using acetate, since it serves as a more
probable mimic of bicarbonate. At pH 8.5, the first-order
rate constant (kcat) experienced a modest decrease from
826 to 664 s1. This inhibition result indicates no sig-
nificant loss in catalytic activity, and illustrates a CA
model capable of preventing product inhibition, which is
a major problem in small molecule models of enzymes.
Overall, our work on Zn(II)-a3DH3 exhibits that we are
successful in recapitulating the primary active site and the
function of carbonic anhydrase in a simplified antiparallel
THB scaffold, a metalloenzyme that is found in a twisted
b-sheet fold in nature.
4. Future Designs
4.1. Redesign of a3DIV to Improve Metal Binding
The structure of a3DIV demonstrates that we are still
able to retain a well-folded peptide construct, even after
mutating the core packing Leu to Cys residues to achieve
a thiol-rich metal-binding site. With this knowledge, we
can now attempt to prepare an antiparallel three-helix
bundle construct (via modeling) that will contain a more
preformed or more symmetric tris(cysteine) metal-bind-
ing site which resembles “a” site ligands. When overlay-
ing the 20 lowest structures of a3DIV, we observed that
the Sg of Cys28 consistently points towards the C-termi-
nal end, forming a skewed S3 plane. Thus, the first itera-
tion involves rearranging the Cys28 by one layer towards
the N-terminal end. This modification requires Cys28Phe
and Phe31Cys mutations (Figure 8a). Along with Cys18
and Cys67, a Cys in the 31st position could produce an S3
plane which is more perpendicular to the helical bundle
than the current a3DIV construct. The Phe in the 28th
position could provide a hydrophobic capping interaction
that forces Cys31 to take an “a” site orientation. We are
currently working on these modifications and plan to
characterize the heavy metal binding properties of this
new a3D construct fully.
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4.2. Redesign of a3DH3 to Improve Catalytic Activity
The crystal structure of Human CAII revealed that
Zn(II) is coordinated to three His residues and a water
molecule/hydroxide ion.[12,39] In addition, this structure ex-
posed an elaborate H-bonding network, facilitated by
Thr, Asn, and Gln residues in the second coordination
sphere. Thr199 forms an H-bonding interaction with the
hydroxide nucleophile of the Zn(II) center, which was de-
termined to be significant for the acid-base catalysis activ-
ity of CA. Mutation studies of this residue resulted in
a 1.5–2.5 unit increase in the pKa (from 6.8) of the H2O
molecule to the OH active form, resulting in 100-fold
loss in catalytic activity.[12,39,63] Our current CA
constructs Zn(II)-a3DH3 and [Hg(II)]S[Zn(II)(H2O/
OH)]N(TRIL9CL23H)3
n+ have pKa values for this de-
protonation process 2–2.6 units higher, and demonstrate
CO2 hydration activities that are 500–1400-fold less effi-
cient than CAII.[11,27,30,61] Nevertheless, both constructs
only contain the primary coordination sphere (ZnHis3)
and do not contain H-bonding interactions that greatly
enhance CA activity. Consequently, to achieve native-like
efficiency, we now have to consider incorporating secon-
dary interactions in our designs. Since our 3SCC ana-
logues are not ideal for adding H-bonding residues inside
the core in a step-wise manner, we must turn to our
a3DH3 to design future CA models which investigate es-
sential secondary interactions (as demonstrated in Fig-
ure 8b).
4.3. Design of an Electron-transfer Site in a3D
Cupredoxins are copper-containing proteins that shuttle
electrons between two-membrane-bound proteins in pho-
tosynthesis, and for this reason, have been extensively
studied to understand their fundamental function in
nature.[64] The copper ion is coordinated to a well-defined
and pre-organized asymmetric metal-binding site encap-
sulated by a b-barrel fold. It contains two histidines, one
cysteine, and one or two more weakly bound residues to
form a 3- to 5-coordinate copper complex. The rack-in-
duced bonding model has been used to describe the
copper site in these cupredoxins, which states that the
ligand environment in a b-barrel fold forces the copper
ion, regardless of the oxidation state, into a strict geome-
try.[65] This feature alone makes cupredoxins an ideal can-
didate for de novo design.
The most successful de novo designed model that dem-
onstrates the spectroscopic properties of cupredoxins was
achieved in a parallel four-stranded coiled-coil.[66] There-
fore, a3D offers a viable framework in achieving an asym-
metric cupredoxin site. Now knowing that we can incor-
porate cysteine ligands in a3DIV and bulky His residues
in a3DH3, we have designed several constructs (Figure 8c)
to test the importance of the b-barrel fold in copper ET
proteins (unpublished work). Ultimately, these designed
constructs will provide a novel approach for investigating
biological long-range electron transfer.
5. Summary and Outlook
De novo protein design is a biologically relevant ap-
proach used to understand the structure-function relation-
ship in the metal centers of native proteins, and is quickly
becoming a viable method for developing heretofore un-
known protein folds with nature-inspired metal-binding
sites. As we have discussed herein, the field of de novo
metalloproteins and enzymology has made great advances
over the past decade and promises the future capability
of preparing multicenter redox enzymes designed from
first principles. At present, well-defined and well-folded
scaffolds have been made available for helical bundle
motifs,[67–70] with the a3D system being an excellent exam-
ple. Here, we have demonstrated that it is possible to
functionalize the a3D scaffold to generate structural and
catalytic sites, while studies are ongoing to generate elec-
tron-transfer centers within the same fold. We and others
intend to build upon this work, constructing nature-in-
spired asymmetric metal-binding sites that form the foun-
dation for future designs of artificial metalloenzymes and
metalloproteins, which not only mimic natural reactions,
but also confer new catalytic processes, ranging from CO2
and H+ reduction to water oxidation and fine chemical
synthesis.
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